Multicollinearity in prognostic factor analyses using the EORTC QLQ-C30: identification and impact on model selection

被引:82
作者
Van Steen, K
Curran, D
Kramer, J
Molenberghs, G
Van Vreckem, A
Bottomley, A
Sylvester, R
机构
[1] Limburgs Univ Ctr, Ctr Stat, B-3590 Diepenbeek, Belgium
[2] Icon Clin Res, Dublin 18, Ireland
[3] Eortc Data Ctr, B-1200 Brussels, Belgium
[4] Europe BMS Waterloo, Div Oncol, B-1410 Waterloo, Belgium
关键词
multicollinearity; prognostic factor analysis; quality of life data; bootstrap;
D O I
10.1002/sim.1358
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Clinical and quality of life (QL) variables from an EORTC clinical trial of first line chemotherapy in advanced breast cancer were used in a prognostic factor analysis of survival and response to chemotherapy. For response, different final multivariate models were obtained from forward and backward selection methods, suggesting a disconcerting instability. Quality of life was measured using the EORTC QLQ-C30 questionnaire completed by patients. Subscales on the questionnaire are known to be highly correlated, and therefore it was hypothesized that multicollinearity contributed to model instability. A correlation matrix indicated that global QL was highly correlated with 7 out of 11 variables. In a first attempt to explore multicollinearity, we used global QL as dependent variable in a regression model with other QL subscales as predictors. Afterwards, standard diagnostic tests for multicollinearity were performed. An exploratory principal components analysis and factor analysis of the QL subscales identified at most three important components and indicated that inclusion of global QL made minimal difference to the loadings on each component. suggesting that it is redundant in the model, In a second approach, we advocate a bootstrap technique to assess the stability of the models. Based on these analyses and since global QL exacerbates problems of multicollinearity, we therefore recommend that global QL be excluded from prognostic factor analyses using the QLQ-C30. The prognostic factor analysis was rerun without global QL in the model, and selected the same significant prognostic factors as before. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:3865 / 3884
页数:20
相关论文
共 36 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   BOOTSTRAP INVESTIGATION OF THE STABILITY OF A COX REGRESSION-MODEL [J].
ALTMAN, DG ;
ANDERSEN, PK .
STATISTICS IN MEDICINE, 1989, 8 (07) :771-783
[3]  
[Anonymous], OXFORD STAT SCI SERI
[4]  
[Anonymous], EORTC QLQ C 30 SCORI
[5]  
Belsley D.A., 1980, Regression Diagnostics: Identifying Influential Data and Sources of Collinearity
[6]   THE PATIENTS PERCEPTION OF HIS OWN QUALITY-OF-LIFE MIGHT HAVE AN ADJUNCTIVE PROGNOSTIC-SIGNIFICANCE IN LUNG-CANCER [J].
BUCCHERI, GF ;
FERRIGNO, D ;
TAMBURINI, M ;
BRUNELLI, C .
LUNG CANCER, 1995, 12 (1-2) :45-58
[7]   PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES IN A TRIAL OF CHEMOTHERAPY WITH OR WITHOUT INTERFERON IN PATIENTS WITH METASTATIC MALIGNANT-MELANOMA [J].
COATES, A ;
THOMSON, D ;
MCLEOD, GRM ;
HERSEY, P ;
GILL, PG ;
OLVER, IN ;
KEFFORD, R ;
LOWENTHAL, RM ;
BEADLE, G ;
WALPOLE, E .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (12) :1731-1734
[8]   Quality of life in oncology practice: Prognostic value of EORTC QLQ-C30 scores in patients with advanced malignancy [J].
Coates, A ;
Porzsolt, F ;
Osoba, D .
EUROPEAN JOURNAL OF CANCER, 1997, 33 (07) :1025-1030
[9]   IMPROVING THE QUALITY-OF-LIFE DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER - A COMPARISON OF INTERMITTENT AND CONTINUOUS TREATMENT STRATEGIES [J].
COATES, A ;
GEBSKI, V ;
BISHOP, JF ;
JEAL, PN ;
WOODS, RL ;
SNYDER, R ;
TATTERSALL, MHN ;
BYRNE, M ;
HARVEY, V ;
GILL, G ;
SIMPSON, J ;
DRUMMOND, R ;
BROWNE, J ;
VANCOOTEN, R ;
FORBES, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (24) :1490-1495
[10]   PROGNOSTIC VALUE OF QUALITY-OF-LIFE SCORES DURING CHEMOTHERAPY FOR ADVANCED BREAST-CANCER [J].
COATES, A ;
GEBSKI, V ;
SIGNORINI, D ;
MURRAY, P ;
MCNEIL, D ;
BYRNE, M ;
FORBES, JF .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (12) :1833-1838